Positron emission tomography with [18F]fluoro-2-deoxyd-D-glucose for diagnosis and staging of bile duct cancer

Hepatology

Volumn 33, Issue 5, 2001, Pages 1029-1035

  Kluge, Regine ^a   Schmidt, Frank ^a   Caca, Karel ^a   Barthel, Henryk ^a   Hesse, Swen ^a   Georgi, Peter ^a   Seese, Anita ^a   Huster, Dominik ^a   Berr, Frieder ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; BILIARY TRACT ENDOSCOPY; CANCER STAGING; CARCINOMATOUS PERITONITIS; CAROLI DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GLUCOSE METABOLISM; HUMAN; INTERMETHOD COMPARISON; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MALIGNANT TRANSFORMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS;

EID: 0035028577     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.23912     Document Type: Article

References (45)

1. Management strategies in resection for hilar cholangiocarcinoma
2. Biliary tract cancers
3. Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade and survival rates
4. Liver resection for hilar and peripheral cholangiocarcinomas: A study of 62 cases
5. Surgical treatment in proximal bile duct cancer. A single-center experience
6. "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention
7. Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors
8. Photodynamic therapy of nonresectable cholangiocarcinoma
9. Photodynamic therapy for advanced bile duct cancer: Evidence for improved palliation and extended survival
10. Neoadjuvant photodynamic therapy before curative resection of proximal bile duct cancer
11. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma
12. Cholangiography in the evaluation of hilar cholangiocarcinoma
13. Endoscopic transpapillary diagnosis of patients with pancreatobiliary ductal strictures
14. [18F]fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer
15. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography
16. Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy
17. Prospective investigation of positron emission tomography in lung nodules
18. Positron-emission tomography for the preoperative staging of head-and-neck tumours
19. Contribution of PET in the diagnosis of recurrent colorectal cancer: Comparison with conventional imaging
20. Malignant melanoma: Staging with whole-body positron emission tomography and 2-[F-18]-Fluoro-2-deoxy-D-glucose
21. 18F-fluorodeoxyglucosepositron-emission tomography with preoperative evaluation of patients with pancreatic masses
22. Overexpression of glucose transporter I and increased F-18 FDG uptake in pancreatic carcinoma
23. Physiochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues
24. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography
25. Evaluation of benign vs malignant hepatic lesions with positron emission tomography
26. Positron emission tomography and cholangiocarcinoma in primary sclerosing cholangitis
27. Staging of hilar bile duct carcinomas with ERC and endoluminal ultrasound or magnetic resonance imaging
28. Accelerated image reconstruction using ordered subsets of projection data
29. ROC methodology in radiological imaging
30. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: Value of quantitative image interpretation
31. Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: A report of 106 cases
32. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma
33. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulocytes studied by microautoradiography
34. Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients
35. Imaging of secondary pulmonary changes in central bronchial carcinoma with 18-FDG PET
36. Positron emission tomography in the evaluation of cholangiocarcinoma
37. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven lung cancer group
38. A PET study of 18FDG uptake in soft tissue masses
39. (F-18) fluorode-oxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma
40. Can the standardized uptake value characterize primary brain tumors on FDG-PET?
41. Simultaneous recovery of size and radioactivity concentration of small spheroids with PET data
42. Peritoneal carcinomatosis - The role of FDG-PET
43. Peritoneal carcinosis
44. Peritoneal carcinomatosis: Preoperative CT with intraperitoneal contrast material